Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme

Digestive and Liver Disease

Volumn 44, Issue 8, 2012, Pages 700-704

  Faivre, Jean ^a   Dancourt, Vincent ^b   Manfredi, Sylvain ^c   Denis, Bernard ^d   Durand, Gérard ^e   Gendre, Isabelle ^d   Bidan, Jeanne Marie ^f   Jard, Christine ^g   Levillain, Romuald ^h   Jung, Sylvie ⁱ   Viguier, Jérôme ^j   Dorval, Etienne ^j  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b Institut Médical de Génétique et d Immunologie   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d ADECA Alsace   (France)

^e ADECI 35   (France)

^f Biological Laboratory of CPAM   (France)

^g Biological Laboratory of CPAM   (France)

^h IRSA Tours   (France)

ⁱ Biological Laboratory of CPAM   (France)

^j UNIVERSITY HOSPITAL OF TOURS   (France)

more..

Author keywords

Faecal occult blood test; Large bowel cancer; Mass screening

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL CANCER; FRANCE; HEMOCCULT II TEST; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; OCCULT BLOOD TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADENOMA; AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FRANCE; GUAIAC; HUMANS; IMMUNOLOGIC TESTS; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS;

EID: 84863783535     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.03.015     Document Type: Article

References (16)

1. Hewitson P., Glasziou P., Watson E., et al. Cochrane systematic review of colorectal cancer screening. Am J Gastroenterol 2008, 103:1541-1549.
2. Council of the European Union. Council recommendation of 2 December 2003 on cancer screening. Official Journal of the European Union. 2003/878/EC, L327/34-38.
3. Goulard H., Boussac-Zarebska M., Ancelle-Park R., et al. J. French colorectal cancer screening pilot programme: results of the first round. J Med Screen 2008, 15:143-148.
4. Van Rossum L.G., Van Rijn A.F., Laheij R.J., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135:82-90.
5. Hol L., Van Leerdam M.E., Van Ballegooijen M., et al. Screening for colorectal cancer: randomized trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoïdoscopy. Gut 2010, 59:62-68.
6. Castiglione G., Grazzini G., Miccinesi G., et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 2002, 9:99-103.
7. Grazzini G., Visioli C.B., Zorri M., et al. Immunochemical faecal occult blood test: number of samples and positivity cut-off. What is the best strategy for colorectal cancer screening?. Br J Cancer 2009, 100:259-265.
8. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007, 56:210-214.
9. Dancourt V., Lejeune C., Lepage C., et al. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 2008, 44:2254-2258.
10. Segnan N., Senore C., Andreoni B., et al. SCORE3 Working Group-Italy. Comparing attendance and detection rate of colonoscopy with sigmoïdoscopy and FIT for colorectal cancer screening. Gastroenterology 2007, 132:2304-2312.
11. Nakama H., Zhang B., Zhang X. The evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer. Eur J Cancer 2001, 37:98-401.
12. Rozen P., Comaneshter D., Levi Z., et al. Cumulative evaluation of a quantitative immunochemical faecal occult blood test to determine its optimal clinical use. Cancer 2010, 116:2115-2125.
13. van Roon A.H., Wilschut J.A., Hol L., et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol 2011, 9:333-339.
14. Van Rossum L.G., Van Rijn A.F., Van Oijen M.G.H., et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening test. Am J Gastroenterol 2005, 100:2519-2525.
15. Vilkin A., Rozen P., Levi Z., et al. Performance characteristics and evaluation of an automated-developed and quantitative immunochemical fecal occult blood screening test. Am J Gastroenterol 2005, 100:2519-2525.
16. Guittet L., Guillaume E., Levillain R., et al. Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 2011, 20:1492-1501.